Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis
Authors:
Open Access
- 24 February 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0116517
Abstract
Survivin has been proposed as a promising prognostic marker in oral squamous cell carcinoma (OSCC), but the published data on survivin expression in patients with this condition are controversial. To address this we performed a meta-analysis systematically to assess the clinicopathological and prognostic significance of survivin expression in OSCC. We searched PubMed, Embase, Web of Science and Ovid databases for papers investigating the clinicopathological and prognostic significance of survivin expression in OSCC. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to determine the relevance of survivin. A total of 15 papers, including 1040 cases in which survivin expression was detected by immunohistochemistry (IHC) or reverse transcription polymerase chain reaction (RT-PCR), were included. A meta-analysis of clinicopathological variables revealed a correlation between survivin expression and lymph node metastasis (OR = 0.62, 95% CI = 0.44–0.88, p < 0.05) and clinical stage (OR = 0.63, 95% CI = 0.41–0.96, p < 0.05). However, no significant associations were found between survivin expression and tumor differentiation grade (OR = 0.72, 95%CI = 0.26–1.11, p > 0.05), depth of invasion (OR = 0.76, 95% CI = 0.50–1.14, p > 0.05), age (OR = 0.78, 95% CI = 0.48–1.29, p > 0.05) or gender (OR = 1.31, 95% CI = 0.86–2.01, p > 0.05). Subgroup analysis using stratified detection methods showed no significant associations between the expression of survivin protein and clinicopathological variables in OSCC. A correlation between survivin expression and poor prognosis of patients with OSCC (HR = 1.62, 95% CI = 1.23–2.01, p < 0.05) was demonstrated. Survivin is a potential prognostic marker of OSCC. Future studies with larger sample sizes and well-designed inclusion criteria will be needed to dissect the role of survivin expression in determining the clinicopathological features and/or prognosis of OSCC.Keywords
This publication has 51 references indexed in Scilit:
- Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysisMolecular Biology Reports, 2013
- Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinomaOncology Letters, 2013
- Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-AnalysisPLOS ONE, 2013
- Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-AnalysisPLOS ONE, 2012
- Survivin expression and targeting in breast cancerSurgical Oncology, 2012
- Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-AnalysisPLOS ONE, 2012
- Survivin gene-expression and splicing isoforms in oral squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2008
- Targeting survivin in cancer therapyExpert Opinion on Therapeutic Targets, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007